ASND Ascendis Pharma A/S
BULLISH
Impact: 9/10
ANALYST-UPGRADE
8 firms acted on ASND: Barclays, Raymond James, Morgan Stanley, RBC Capital, UBS, Oppenheimer, TD Cowen, Stifel
Latest settled — T+20d
ASND ▲ +0.26% at T+20d
LONG call ✓ call won +0.26% · α vs SPY -5.56% · entry $242.95 → $243.58
Currently $209.41 · -13.80% from $242.95 entry
T+1d
+0.63%
call +0.63% · α -0.58%
$244.48
settled 8w ago
T+5d
-7.39%
call -7.39% · α -8.37%
$225.00
settled 7w ago
T+20d
+0.26%
call +0.26% · α -5.56%
$243.58
settled 27d ago
T+60d
—
call — · α —
—
in 5w
Price Chart
Loading chart...
Executive Summary
Morgan Stanley upgraded ASND from Equal-Weight to Overweight with a $250 price target, up from $180, implying 13.4% upside from the current $220.48. The firm has a 54.9% accuracy rate (2,744/4,993 calls correct), with an average return of 4.3% on rated stocks. The 16-analyst consensus implies a mean target of $294.27, suggesting 33% upside.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-16 | B of A Securities | maintain | Buy | $292.00 |
| 2026-04-09 | Wedbush | reiterate | Outperform | $273.00 |
| 2026-03-03 | RBC Capital | maintain | Outperform | — |
| 2026-02-12 | Oppenheimer | maintain | Outperform | $262.00 |
| 2026-02-12 | Wedbush | maintain | Outperform | $273.00 |
Documents Analyzed
Report based on filing metadata.
14 reports for ASND
78%
Hit rate
best @ T+5▲ +13.32%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
7d ago
|
Insider Cluster
| $216.79 $218.84 | ▲ +0.95% | ▲ +0.55% | $209.41 (−3.40%) |
|
May 19, 2026
22d ago
|
ANALYST-UPGRADE
| $237.98 $241.34 | ▲ +1.41% | ▲ +0.37% | $209.41 (−12.00%) |
|
May 16, 2026
24d ago
|
ANALYST-UPGRADE
| $170.74 $162.84 | ▼ −4.63% | ▼ −3.78% | $209.41 (+22.65%) |
|
May 7, 2026
4w ago
|
6-K
| $246.14 $238.66 | ▼ −3.04% | ▼ −3.87% | $209.41 (−14.92%) |
|
May 7, 2026
4w ago
|
6-K
| $246.14 $238.66 | ▼ −3.04% | ▼ −3.87% | $209.41 (−14.92%) |
|
May 6, 2026
4w ago
|
Press Release
| $246.14 $246.14 | · 0.00% | ▼ −0.83% | $209.41 (−14.92%) |
|
Apr 21, 2026
7w ago
|
6-K
| $240.29 $231.05 | ▼ −3.85% | ▼ −4.86% | $209.41 (−12.85%) |
|
Apr 16, 2026
7w ago
|
ANALYST-UPGRADE
| $242.95 $244.48 | ▲ +0.63% | ▼ −0.58% | $209.41 (−13.80%) |
|
Apr 8, 2026
8w ago
|
6-K
| $241.71 $239.28 | ▼ −1.01% | ▼ −0.94% | $209.41 (−13.36%) |
|
Apr 8, 2026
8w ago
|
6-K
| $241.71 $239.28 | ▼ −1.01% | ▼ −0.94% | $209.41 (−13.36%) |
Showing 10 of 14
US Market Status
Market Open — Closes in 1h 16m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access